Aperio Group’s OptiNose OPTN Stock Holding History

Aperio Group’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-44	Closed	-$5K	–	2621
2019 Q2	$5K	Buy	+44	New	+$5.8K	﹤0.01%	2859

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aperio Group's OPTN Position: Q3 2019 in Review

Aperio Group sold out of OptiNose (OPTN) in Q3 2019, closing a stake of 44 shares — an estimated $5K sold.

Aperio Group first reported a position in OPTN in Q2 2019 and held it in 1 quarter. The position peaked at $5K in Q2 2019. 77 funds tracked by Wall St. Rank hold OPTN as of Q3 2019.

Aperio Group reported no remaining OptiNose position as of Q3 2019 after selling out during the quarter.
Aperio Group sold 44 OptiNose shares in Q3 2019, an estimated $5K.
Aperio Group first reported a position in OptiNose in Q2 2019 and held it in 1 quarter.
Aperio Group's OptiNose position peaked at $5K in Q2 2019.
77 funds tracked by Wall St. Rank held OptiNose as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.